Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Retained Earnings (2014 - 2026)

Mesoblast's (MEOBF) quarterly Retained Earnings came in at -$1.1 billion in Q2 2026, down 5.69% year-over-year from -$1.1 billion in Q2 2025, and down 1.65% quarter-over-quarter from -$1.1 billion in Q4 2025.

Analysis

Mesoblast (MEOBF) Retained Earnings (2014 - 2026) Analysis & Trends

Mesoblast has disclosed Retained Earnings across 13 years of filings, most recently posting -$1.1 billion for Q2 2026.

  • In Q2 2026, Retained Earnings fell 5.69% year-over-year to -$1.1 billion; the TTM figure through Jun 2026 stood at -$1.1 billion (down 5.69% YoY), while the FY2026 annual figure was -$1.1 billion, down 5.69% from the prior year.
  • Retained Earnings came in at -$1.1 billion for Q2 2026 at Mesoblast, down from -$1.1 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$717.5 million in Q1 2022 to a low of -$1.1 billion in Q2 2026.
  • Average Retained Earnings over 5 years is -$871.8 million, with a median of -$837.1 million recorded in 2023.
  • Year-over-year, Retained Earnings slipped 14.7% in 2022 and fell 5.69% in 2026.
  • Over 5 years, Retained Earnings stood at -$780.3 million in 2022, then dropped by 9.36% to -$853.3 million in 2023, then dropped by 12.11% to -$956.7 million in 2024, then declined by 9.86% to -$1.1 billion in 2025, then decreased by 1.65% to -$1.1 billion in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$1.1 billion in Q2 2026, -$1.1 billion in Q4 2025, and -$1.0 billion in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.23 Bn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -2.16 Bn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 3.62 Bn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.23 Bn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 1.84 Bn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 2.93 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 2.37 Bn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -4.55 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -380.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.07 Bn
Dec 31, 2025 -1.05 Bn
Jun 30, 2025 -1.01 Bn
Dec 31, 2024 -956.70 Mn
Jun 30, 2024 -908.76 Mn
Dec 31, 2023 -853.34 Mn
Jun 30, 2023 -820.81 Mn
Mar 31, 2023 -798.89 Mn
Dec 31, 2022 -780.29 Mn
Sep 30, 2022 -755.80 Mn
Jun 30, 2022 -738.92 Mn
Mar 31, 2022 -717.46 Mn
Dec 31, 2021 -696.16 Mn
Sep 30, 2021 -670.21 Mn
Jun 30, 2021 -647.57 Mn
Mar 31, 2021 -625.51 Mn
Dec 31, 2020 -598.99 Mn
Sep 30, 2020 -573.30 Mn
Jun 30, 2020 -548.76 Mn
Mar 31, 2020 -516.15 Mn